Terns Pharmaceuticals, Inc.Terns Pharmaceuticals, Inc.Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪327.14 M‬USD
−1.27USD
‪−90.21 M‬USD
‪41.12 M‬
Beta (1Y)
−0.45

About Terns Pharmaceuticals, Inc.

CEO
Amy L. Burroughs
Headquarters
Foster City
Employees (FY)
66
Founded
2017
ISIN
US8808811074
FIGI
BBG00KK1SJ08
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TERN is 5.06 USD — it has decreased by 1.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Terns Pharmaceuticals, Inc. stocks are traded under the ticker TERN.
Terns Pharmaceuticals, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Terns Pharmaceuticals, Inc. has a max estimate of 22.00 USD and a min estimate of 5.50 USD.
TERN earnings for the last quarter are −0.42 USD whereas the estimation was −0.31 USD which accounts for −37.46% surprise. Estimated earnings for the next quarter are −0.29 USD. See more details about Terns Pharmaceuticals, Inc. earnings.
Yes, you can track Terns Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, TERN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Terns Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
TERN reached its all-time high on Mar 19, 2021 with the price of 28.36 USD, and its all-time low was 1.45 USD and was reached on May 20, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 66.00 employees. See our rating of the largest employees — is Terns Pharmaceuticals, Inc. on this list?